Dr. Gabriel Tinoco, MD

Claim this profile

The Ohio State University (Data Collection Only)

Studies Soft Tissue Sarcoma
Studies Uterine Leiomyosarcoma
3 reported clinical trials
4 drugs studied

Area of expertise

1

Soft Tissue Sarcoma

Gabriel Tinoco, MD has run 1 trial for Soft Tissue Sarcoma. Some of their research focus areas include:

Stage IV
Stage III
2

Uterine Leiomyosarcoma

Gabriel Tinoco, MD has run 1 trial for Uterine Leiomyosarcoma. Some of their research focus areas include:

Stage IV
Stage III

Affiliated Hospitals

Image of trial facility.

The Ohio State University (Data Collection Only)

Image of trial facility.

The Ohio State University

Clinical Trials Gabriel Tinoco, MD is currently running

More about Gabriel Tinoco, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Gabriel Tinoco, MD has experience with

  • All-Trans Retinoic Acid (ATRA)
  • Cemiplimab
  • AG-120
  • SPH4336

Breakdown of trials Gabriel Tinoco, MD has run

Uterine Leiomyosarcoma

Follicular Lymphoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Gabriel Tinoco, MD specialize in?

Is Gabriel Tinoco, MD currently recruiting for clinical trials?

Are there any treatments that Gabriel Tinoco, MD has studied deeply?

What is the best way to schedule an appointment with Gabriel Tinoco, MD?

What is the office address of Gabriel Tinoco, MD?

Is there any support for travel costs?